- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Faculty Research and Publications /
- Intravenous (IV) iron for severe iron deficiency
Open Collections
UBC Faculty Research and Publications
Intravenous (IV) iron for severe iron deficiency Therapeutics Initiative (University of British Columbia)
Description
Therapeutics Letter 97 examines intravenous (IV) iron for severe iron deficiency. Conclusions Intravenous iron markedly benefits appropriately selected people with chronic severe iron deficiency. Rare but potentially fatal reactions occur with all IV iron products. This requires administration in a setting where immediate treatment is available, including adrenaline. No formulation is proven to be safer than others. IV iron is preferable to IM injection.
Item Metadata
Title |
Intravenous (IV) iron for severe iron deficiency
|
Alternate Title |
Therapeutics Letter 97
|
Creator | |
Date Issued |
2015-12
|
Description |
Therapeutics Letter 97 examines intravenous (IV) iron for severe iron deficiency. Conclusions Intravenous iron markedly benefits appropriately selected people with chronic severe iron deficiency. Rare but potentially fatal reactions occur with all IV iron products. This requires administration in a setting where immediate treatment is available, including adrenaline. No formulation is proven to be safer than others. IV iron is preferable to IM injection.
|
Subject | |
Genre | |
Type | |
Language |
eng
|
Notes |
The UBC TI is funded by the BC Ministry of Health to provide evidence-based information about drug therapy. We neither formulate nor adjudicate provincial drug policies.
|
Date Available |
2023-06-20
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
Attribution-NonCommercial-NoDerivatives 4.0 International
|
DOI |
10.14288/1.0433676
|
URI | |
Affiliation | |
Peer Review Status |
Reviewed
|
Scholarly Level |
Faculty; Researcher
|
Rights URI | |
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International